Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jan 4, 2005
A live webcast and replay of the January 10th session will be available. Learn how to tune in for the presentation.
-
Dec 31, 2004
Jim Tobin, President and CEO, calls Company’s 2004 performance “nothing short of remarkable and speaks to a truly global effort."
-
Dec 30, 2004
Money is being directed to the Red Cross' International Response Fund.
-
Dec 20, 2004
Expansion of management structure is designed to position the Company for continued growth and success.
-
Dec 16, 2004
The transaction is expected to close early next year.
-
Dec 2, 2004
Motions for summary judgment were granted in part and denied in part.
-
Nov 24, 2004
A live webcast and replay of the December 1 conference session will be available.
-
Nov 23, 2004
An existing licensing agreement with Angiotech Pharmaceuticals, Inc. allows Company to obtain an exclusive license for the use of paclitaxel and other agents in the coronary vascular field.
-
Nov 22, 2004
French government adds new patient categories to reimbursement approval criteria.
-
Nov 18, 2004
Company plans to use the proceeds to repay commercial paper borrowings and for other general corporate purposes.